{
  "company": {
    "name": "Chimeron Bio",
    "website": "https://chimeron.com/",
    "record": "https://startuphistory.org/c/chimeron.com"
  },
  "status": null,
  "history_since": "2017-07-10T18:05:04.000Z",
  "baseline": {
    "snapshot_id": "d964f4877a8d4b5668f4a550d05640dffd49f0228743140b6361ac61d2572449",
    "observed_at": "2017-07-10T18:05:04.000Z",
    "headline": null,
    "description": "Chimeron Bio is committed to discovering and developing personalized immunotherapeutics that will revolutionize the treatment of cancer.",
    "evidence": "https://web.archive.org/web/20170710180504/https://chimeron.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 0,
  "last_checked": null,
  "live_status": "offline",
  "messaging": [
    {
      "quote_observed_at": "2023-02-01T15:30:40.000Z",
      "variants": [
        {
          "headline": "Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.",
          "subhead": "Chimeron Bio is combining a first-in-class platform & the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics.",
          "observed_at": "2021-01-18T01:27:03.000Z",
          "evidence": "https://web.archive.org/web/20210118012703/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.",
          "subhead": "Chimeron Bio is combining a first-in-class platform & the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics.",
          "observed_at": "2022-01-17T14:45:31.000Z",
          "evidence": "https://web.archive.org/web/20220117144531/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.",
          "subhead": "Chimeron Bio is combining a first-in-class platform & the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics.",
          "observed_at": "2023-02-01T15:30:40.000Z",
          "evidence": "https://web.archive.org/web/20230201153040/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.",
      "subhead": "Chimeron Bio is combining a first-in-class platform & the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics.",
      "from": "2021-01-18T01:27:03.000Z",
      "to": "2023-02-01T15:30:40.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20230201153040/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-01-18T01:27:03.000Z",
          "to": "2023-02-01T15:30:40.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2024-01-04T15:12:06.000Z",
      "variants": [
        {
          "headline": "Future Forward.",
          "subhead": "Future Forward. Next generation RNA technology. OUR UNIQUE APPROACH Our Vision Chimeron Bio is redefining genetic medicine with future-forward RNA technology designed to deliver meaningful results for",
          "observed_at": "2024-01-04T15:12:06.000Z",
          "evidence": "https://web.archive.org/web/20240104151206/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Future Forward.",
      "subhead": "Future Forward. Next generation RNA technology. OUR UNIQUE APPROACH Our Vision Chimeron Bio is redefining genetic medicine with future-forward RNA technology designed to deliver meaningful results for",
      "from": "2024-01-04T15:12:06.000Z",
      "to": "2024-01-04T15:12:06.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20240104151206/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2024-01-04T15:12:06.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-07-26T14:17:24.000Z",
      "variants": [
        {
          "headline": "Harnessing Genetic Medicine & saRNA to Transform Oncology",
          "subhead": "Harnessing Genetic Medicine & saRNA to Transform Oncology Developing in vivo CAR, immuno-oncology, and cancer vaccine therapeutics. OUR UNIQUE APPROACH Our Mission We’re dedicated to advancing genetic",
          "observed_at": "2025-01-10T11:26:01.000Z",
          "evidence": "https://web.archive.org/web/20250110112601/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Harnessing Genetic Medicine & saRNA to Transform Oncology",
          "subhead": "Harnessing Genetic Medicine & saRNA to Transform Oncology Developing in vivo CAR, immuno-oncology, and cancer vaccine therapeutics. OUR UNIQUE APPROACH Our Mission We’re dedicated to advancing genetic",
          "observed_at": "2025-07-26T14:17:24.000Z",
          "evidence": "https://web.archive.org/web/20250726141724/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Harnessing Genetic Medicine & saRNA to Transform Oncology",
      "subhead": "Harnessing Genetic Medicine & saRNA to Transform Oncology Developing in vivo CAR, immuno-oncology, and cancer vaccine therapeutics. OUR UNIQUE APPROACH Our Mission We’re dedicated to advancing genetic",
      "from": "2025-01-10T11:26:01.000Z",
      "to": "2025-07-26T14:17:24.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20250726141724/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2025-01-10T11:26:01.000Z",
          "to": "2025-07-26T14:17:24.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-06-09T15:32:04.000Z",
      "variants": [
        {
          "headline": "Pioneering MultiPlex In-Vivo CAR-T Therapy",
          "subhead": "Pioneering MultiPlex In-Vivo CAR-T Therapy A new wave in genetic medicine – multiplexed, precise, and delivered at scale. DISCOVER OUR APPROACH Breakthrough Science MultiPlex genetic engineering previ",
          "observed_at": "2026-01-20T21:56:09.000Z",
          "evidence": "https://web.archive.org/web/20260120215609/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering MultiPlex In-Vivo CAR-T Therapy",
          "subhead": "Pioneering MultiPlex In-Vivo CAR-T Therapy A new wave in genetic medicine – multiplexed, precise, and delivered at scale. DISCOVER OUR APPROACH Breakthrough Science MultiPlex genetic engineering previ",
          "observed_at": "2026-06-09T15:32:04.000Z",
          "evidence": "https://web.archive.org/web/20260609153204/https://www.chimeron.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Pioneering MultiPlex In-Vivo CAR-T Therapy",
      "subhead": "Pioneering MultiPlex In-Vivo CAR-T Therapy A new wave in genetic medicine – multiplexed, precise, and delivered at scale. DISCOVER OUR APPROACH Breakthrough Science MultiPlex genetic engineering previ",
      "from": "2026-01-20T21:56:09.000Z",
      "to": "2026-06-09T15:32:04.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20260609153204/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2026-01-20T21:56:09.000Z",
          "to": "2026-06-09T15:32:04.000Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-25040548925c22291bc96aed74889a64e6733fa3065925b121d799654b80560a:dddf545b2448e671ff1a84e966460510a971b36b207aae1696fa3137c12853da:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20190818201658/https://www.chimeron.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2019-08-18T20:16:58.000Z",
        "to": "2021-01-18T01:27:03.000Z"
      },
      "evidence": "https://web.archive.org/web/20210118012703/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 2,
      "id": "page-f35b82a5ed07b24990525be3f6e83758bdd571c4178ea20110c098ae6e3cde9e:4fe556d1c20e5a142ca29165168a5365d299c6eb4ab626c160773aca9b042599:headline:6553e5b82738c852",
      "before_evidence": "https://web.archive.org/web/20230201153040/https://www.chimeron.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.” to “Future Forward.”.",
      "between": {
        "from": "2023-02-01T15:30:40.000Z",
        "to": "2024-01-04T15:12:06.000Z"
      },
      "evidence": "https://web.archive.org/web/20240104151206/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "classifier-4fe556d1c20e5a142ca29165168a5365d299c6eb4ab626c160773aca9b042599:fc0fd602c6e91d433654c36c7f4a38b8c34dcfbebfd73ea4b5b93681d4de35f5:repositioning",
      "before_evidence": "https://web.archive.org/web/20240104151206/https://www.chimeron.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "repositioning",
      "label": "Messaging",
      "summary": "Changed its homepage headline from “Future Forward.” to “Harnessing Genetic Medicine & saRNA to Transform Oncology”.",
      "between": {
        "from": "2024-01-04T15:12:06.000Z",
        "to": "2025-01-10T11:26:01.000Z"
      },
      "evidence": "https://web.archive.org/web/20250110112601/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "basis": "classifier",
      "topic": "https://startuphistory.org/t/repositioned"
    },
    {
      "n": 4,
      "id": "page-f85bf6c8f3ad662c0c6b5dd6aee8fe79caff38108368564d685eedb6548dc583:cfc3fdfe49466ddaaf4aaa2e0f195ae9b116b62ca9b084ba1c2f094bd7d4f88c:headline:bfa5ecfa4d2fa4fa",
      "before_evidence": "https://web.archive.org/web/20250726141724/https://www.chimeron.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Harnessing Genetic Medicine & saRNA to Transform Oncology” to “Pioneering MultiPlex In-Vivo CAR-T Therapy”.",
      "between": {
        "from": "2025-07-26T14:17:24.000Z",
        "to": "2026-01-20T21:56:09.000Z"
      },
      "evidence": "https://web.archive.org/web/20260120215609/https://www.chimeron.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": {
    "headline": "Chimeron Bio now highlights multiplex in‑vivo CAR‑T therapy",
    "summary": "Chimeron Bio’s website messaging has shifted from broad RNA therapy and synthetic genomics to a focus on multiplex in‑vivo CAR‑T therapy, with intermediate emphasis on genetic medicine and saRNA, and the company has also introduced a careers page.",
    "points": [
      {
        "text": "Between July 2025 and January 2026, Chimeron Bio changed its homepage headline to “Pioneering MultiPlex In-Vivo CAR-T Therapy”.",
        "kind": "fact",
        "changes": [
          4
        ]
      },
      {
        "text": "Between January 2024 and January 2025, a classifier read Chimeron Bio’s homepage change to “Harnessing Genetic Medicine & saRNA to Transform Oncology” as a repositioning.",
        "kind": "fact",
        "changes": [
          3
        ]
      },
      {
        "text": "Between February 2023 and January 2024, Chimeron Bio changed its homepage headline from “Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.” to “Future Forward.”",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "Between August 2019 and January 2021, Chimeron Bio added a careers page to its website.",
        "kind": "fact",
        "changes": [
          1
        ]
      }
    ],
    "written_at": "2026-11-07T21:07:16.366Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Chimeron Bio” company record, https://startuphistory.org/c/chimeron.com"
}